PATENT CLAIM ANALYSIS

Application Number: 15949736
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "653000"]

Abstract:
The inventive subject matter is directed to compositions and methods for ready-to-inject norepinephrine compositions with improved stability. Most preferably, compositions presented herein are substantially antioxidant free and exhibit less than 10% isomerization of R-nor epinephrine and exhibit less than 5% degradation of total norepinephrine.

Claim (Index 17):
The composition of  claim 1  wherein equal or less than 6% of the R-isomer form will isomerize to the S-isomer.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 91.0
- Lexical Diversity: 1.28947
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15883798', '14837749', '15058602', '13541524', '15663246']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.750120631717588
- 35 USC 102 Novelty (BERT): 0.5882192636238225
- Combined Prediction Score: 0.7339304949082115
- Mean Citation Score: 255.7146
- Max Citation Score: 486.84943
- Similarity Product: 439.3376347985542

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test